| Literature DB >> 27134664 |
Camila González-Arancibia1, Jorge Escobar-Luna1, Camila Barrera-Bugueño1, Camilo Díaz-Zepeda1, María P González-Toro1, Loreto Olavarría-Ramírez1, Francesca Zanelli-Massai1, Martin Gotteland2, Javier A Bravo1, Marcela Julio-Pieper3.
Abstract
The gut and the brain communicate bidirectionally through anatomic and humoral pathways, establishing what is known as the gut-brain axis. Therefore, interventions affecting one system will impact on the other, giving the opportunity to investigate and develop future therapeutic strategies that target both systems. Alterations in the gut-brain axis may arise as a consequence of changes in microbiota composition (dysbiosis), modifications in intestinal barrier function, impairment of enteric nervous system, unbalanced local immune response and exaggerated responses to stress, to mention a few. In this review we analyze and discuss several novel pharmacological targets within the gut-brain axis, with potential applications to improve intestinal and mental health.Entities:
Keywords: enteric nervous system; gut–brain axis; interleukin 22; intestinal microbiota; serotonin; vagus nerve
Year: 2016 PMID: 27134664 PMCID: PMC4830101 DOI: 10.1177/1756283X16630718
Source DB: PubMed Journal: Therap Adv Gastroenterol ISSN: 1756-283X Impact factor: 4.409